Thursday, September 03, 2020 11:04:55 AM
Agree. Have owned the stock as long as you.
This go 'round, Dahl is on the proxy as a director. Don't think I ever saw why Rice was taken off the BoD as Chair (shouldn't have been in the first place) .... and don't recall any external notice of John Payne taking over as Chairman other than seeing it in the proxy.
I don't know how any investors could vote for anyone outside of Maggiore on this BoD. Maybe I am completely missing the boat but its past time. Human GRAS was done almost 2 years ago. Have a novel NSP complex identified. There isn't an excuse any longer.
Dahl obviously has not been able to raise money or sell the idea to anyone. Can't say I like the pre revenue funding they've now started to sign but don't know if that means ZIVO thinks they are about to ink licensing deals or not. I would think so .... but nothing this company does makes much sense. As I noted yesterday, other algae companies are already doing and done what Dahl puts forth ..... they have their own staffs and facilities and have gotten millions in funding and gotten chit done. Been waiting on Dahl talking about selling dried biomass as a dye like everyone else. But all we get from Dahl ..... excuses.
Yes Covid is a problem for 2020 and potentially beyond. I will grant that .... but I also think Covid could have been an opportunity. Were I CEO, at the minimum I would have had it evaluated as a potential option for Covid (find a way) and determined whether it had any potential to help .... AND I WOULD TELL MY SHAREHOLDERS ABOUT IT GOOD OR BAD (transparency). THERE WERE AND ARE SCIENTISTS WORKING THE PROBLEM ALL OVER THE WORLD IN SPITE OF THE SHUTDOWN. ZIVO would have YEARS of test data showing its effect on cytokines. You hear about "cytokine storms" in Covid patients. Already known to enhance immune response.
Hell I happened to own a few shares of a OTC company that makes diving equipment .... NOT A DAMN THING TO DO WITH MEDICAL ANYTHING ..... they have a portable tankless diving system that pumps air to a diver ... earlier this year they jumped in and converted their portable breathing apparatus into a cheap and simple ventilator.
https://www.diveblu3.com/blu3-vent/
Of course there are stories all over the place like this of companies finding a way. ZIVO HAS A PRODUCT KNOWN TO ENHANCE THE IMMUNE SYSTEM AND REGULATE CYTOKINES. So I ask ...... what did/has ZIVO done on this front ?
Bottomline for me. No confidence in Dahl and Rice. I was very skeptical they would be right for anything beyond the turnaround of the company. Their contracts are ridiculous for the work performed. Last year's massive awards .... I don't get it. They can't raise the money and get things done in a timely manner. To say the doors are still open is nice but at the expense of shareholders and the capital structure ... not to mention time has a cost as well .... while others innovate and move ahead ... ZIVO stands still .....
Dahl .... PRODUCER or PARASITE ?? .... longtimers may know this reference.
Amigo Mike
Recent ZIVO News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/26/2024 05:36:56 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/26/2024 12:05:12 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 04/09/2024 03:49:14 PM
- Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 03/14/2024 01:16:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:45:37 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 02/15/2024 01:54:37 PM
- ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study • Business Wire • 02/07/2024 09:54:00 PM
- ZIVO Bioscience Announces Uplisting to OTCQB Market • Business Wire • 01/29/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 09:11:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:17:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:05:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:23:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:12:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/27/2023 02:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/22/2023 09:21:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:18:41 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 10/30/2023 05:20:31 PM
- ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens • Business Wire • 10/30/2023 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 12:56:59 PM
- ZIVO Bioscience Announces Reverse Stock Split • Business Wire • 10/26/2023 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 10/04/2023 09:08:51 PM
- ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference • GlobeNewswire Inc. • 10/03/2023 12:30:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM